Trade IRD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Opus Genetics, Inc. (IRD) is trading at US$4.74, up 1.83% today as of Oct 12, 14:41 EDT. The company has a market capitalisation of US$336.94M. Over the past 52 weeks, IRD has traded between US$1.70 and US$7.07. On Syfe you can trade IRD with $0 commission and add it to your watchlist.
| Previous close | US$4.65 |
|---|---|
| Market cap | US$336.94M |
| 52-week range | US$1.70 – US$7.07 |
| Volume | 1.26M |
| Exchange | US |
Opus Genetics, Inc.
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
Year: 2020
Wedbush Raises Price Target on Opus Genetics to $13 From $10, Keeps Outperform Rating
Sep 10, 11:43 AM · MT Newswires
Correction: Chardan Raises Price Target on Opus Genetics to $16 From $13, Keeps Buy Rating
Sep 10, 11:40 AM · MT Newswires
Sector Update: Healthcare Stocks Softer Late Afternoon
Sep 9, 7:49 PM · MT Newswires
Update: Opus Genetics Shares Rise After Reporting Vision Improvement in Phase 1/2 OPGx-BEST1 Trial
Sep 9, 6:35 PM · MT Newswires
Wedbush Raises Opus Genetics Price Target to $13 From $10, Maintains Outperform Rating
Sep 9, 4:34 PM · MT Newswires
Opus Genetics, Inc. (IRD) stock is trading at US$4.74, +1.83% from the previous close of US$4.65.
The market cap for Opus Genetics, Inc. (IRD) stock is approximately US$336.94M.
The 52-week high for Opus Genetics, Inc. (IRD) stock is US$7.07.
The 52-week low for Opus Genetics, Inc. (IRD) stock is US$1.70.
Opus Genetics, Inc. (IRD) does not currently pay a dividend.
Stay on top of IRD
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
